Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODAt Study
2010-020442-10Phase 3Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Atazanavir/ritonavir monotherapy with Atazanavir/ritonavir-based HAART (2 arms). Primary endpoint: Confirmed virological failure at week 48. Started May 2010; status: completed.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-020442-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020442-10.